GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 202 filers reported holding GERON CORP in Q3 2023. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $634,248 | -12.5% | 299,175 | +32.5% | 0.00% | 0.0% |
| Q2 2023 | $724,547 | +52.6% | 225,717 | +3.2% | 0.00% | 0.0% |
| Q1 2023 | $474,827 | -6.2% | 218,817 | +4.6% | 0.00% | 0.0% |
| Q4 2022 | $506,000 | +5.9% | 209,112 | +2.4% | 0.00% | 0.0% |
| Q3 2022 | $478,000 | +61.5% | 204,184 | +7.4% | 0.00% | 0.0% |
| Q2 2022 | $296,000 | +28.7% | 190,079 | +12.4% | 0.00% | – |
| Q1 2022 | $230,000 | +12.7% | 169,079 | +1.8% | 0.00% | – |
| Q4 2021 | $204,000 | -15.0% | 166,079 | -5.1% | 0.00% | -100.0% |
| Q3 2021 | $240,000 | +3.9% | 175,079 | +6.7% | 0.00% | 0.0% |
| Q2 2021 | $231,000 | +55.0% | 164,099 | +74.4% | 0.00% | – |
| Q1 2021 | $149,000 | -2.6% | 94,087 | -1.6% | 0.00% | – |
| Q4 2020 | $153,000 | -6.7% | 95,645 | +1.5% | 0.00% | – |
| Q3 2020 | $164,000 | -11.8% | 94,197 | +10.7% | 0.00% | -100.0% |
| Q2 2020 | $186,000 | +121.4% | 85,130 | +18.2% | 0.00% | – |
| Q1 2020 | $84,000 | – | 72,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 23,375,839 | $49,556,779 | 7.30% |
| MPM BioImpact LLC | 10,712,481 | $22,710,460 | 6.06% |
| Ally Bridge Group (NY) LLC | 2,221,639 | $4,709,875 | 5.53% |
| Vivo Capital, LLC | 16,524,634 | $35,032,224 | 3.84% |
| NEA Management Company, LLC | 22,776,409 | $48,285,987 | 3.73% |
| Deep Track Capital, LP | 25,700,000 | $54,484,000 | 2.10% |
| RA Capital Management | 46,202,425 | $97,949,141 | 1.93% |
| Velan Capital Investment Management LP | 778,500 | $1,650,420 | 1.33% |
| Opaleye Management Inc. | 1,915,000 | $4,059,800 | 1.32% |
| Nan Fung Group Holdings Ltd | 753,550 | $1,597,526 | 1.29% |